Glycorex Transplantation
2.13
SEK
+0.47 %
Less than 1K followers
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+0.47%
-22.26%
+4.41%
+18.01%
+53.24%
+126.6%
-66.19%
-79.71%
-79.02%
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Read moreMarket cap
167.96M SEK
Turnover
15.45K SEK
Revenue
35.16M
EBIT %
-29.69 %
P/E
-
Dividend yield-%
-
Financial calendar
23.5
2025
Interim report Q1'25
27.5
2025
General meeting '25
29.8
2025
Interim report Q2'25
ShowingAll content types
Glycorex Transplantation AB: First ABO-incompatible transplantation in Portugal with Glycosorb® ABO
Glycorex Transplantation AB (GTAB B): First blood group-incompatible pediatric heart transplantation in Austria using Glycosorb® ABO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools